Yuxin Duan

State Key Laboratory Of Water Pollution Control And Green Resource Recycling
Nanjing, 210023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Electroactive Materials for Anaerobic Bioenergy and Bioproduct Recovery from Wastewater: Decoding Tripartite Interfaces in Microbial Electron Transfer.

Electroactive Materials for Anaerobic Bioenergy and Bioproduct Recovery from Wastewater: Decoding Tripartite Interfaces in Microbial Electron Transfer.

Journal: Environmental science & technology

Published: May 07, 2026

Global, regional and national burden of liver cancer in middle-aged and older adults from 1990 to 2021: a comprehensive analysis with cross-country inequality, decomposition, and frontier analysis.

Global, regional and national burden of liver cancer in middle-aged and older adults from 1990 to 2021: a comprehensive analysis with cross-country inequality, decomposition, and frontier analysis.

Journal: Clinical and translational gastroenterology

Published: March 15, 2026

Prognostic value of the platelet-to-lymphocyte ratio for recurrent hemoptysis following bronchial artery embolization in patients with ronchiectasis.

Prognostic value of the platelet-to-lymphocyte ratio for recurrent hemoptysis following bronchial artery embolization in patients with ronchiectasis.

Journal: Medicine

Published: December 18, 2025

Prognostic value of blood urea nitrogen to albumin ratio in critically ill cirrhotic patients with ascites.

Prognostic value of blood urea nitrogen to albumin ratio in critically ill cirrhotic patients with ascites.

Journal: Scientific reports

Published: November 20, 2025

Machine learning-based risk stratification for gastrointestinal bleeding in ICU patients with cirrhosis: evidence from the MIMIC database.

Machine learning-based risk stratification for gastrointestinal bleeding in ICU patients with cirrhosis: evidence from the MIMIC database.

Journal: Frontiers in medicine

Published: September 29, 2025

Adverse reactions of second-line tyrosine kinase inhibitors in advanced hepatocellular carcinoma treatment: a descriptive analysis from WHO-VigiAccess.

Adverse reactions of second-line tyrosine kinase inhibitors in advanced hepatocellular carcinoma treatment: a descriptive analysis from WHO-VigiAccess.

Journal: Translational gastroenterology and hepatology

Published: July 17, 2025

Bronchiectasis morphology and hemoptysis recurrence after bronchial artery embolization: a cohort study using inverse probability of treatment weighting.

Bronchiectasis morphology and hemoptysis recurrence after bronchial artery embolization: a cohort study using inverse probability of treatment weighting.

Journal: Frontiers in medicine

Published: June 11, 2025

Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery embolization.

Development and validation of a nomogram for predicting hemoptysis recurrence in cystic bronchiectasis patients following bronchial artery embolization.

Journal: Frontiers in medicine

Published: February 23, 2025

Multi-omics approaches for identifying the PANoptosis signature and prognostic model via a multimachine-learning computational framework for intrahepatic cholangiocarcinoma.

Multi-omics approaches for identifying the PANoptosis signature and prognostic model via a multimachine-learning computational framework for intrahepatic cholangiocarcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: September 23, 2024

The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy.

The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy.

Journal: Bioscience trends

Published: November 19, 2023

A well-matched marriage of immunotherapy and radiofrequency ablation to reduce the relapse and progression of hepatocellular carcinoma.

A well-matched marriage of immunotherapy and radiofrequency ablation to reduce the relapse and progression of hepatocellular carcinoma.

Journal: Bioscience trends

Published: September 11, 2022

Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes.

Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes.

Journal: Bioscience trends

Published: August 07, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026